Matinas Biopharma Holdings, Inc. (MTNB) SEC Filings — 2025

Filings

• Matinas BioPharma Files 8-K: Officer/Director Changes & Financials — 8-K · Dec 12, 2025
• Matinas BioPharma Announces Executive and Director Changes — 8-K · Nov 21, 2025
• Matinas BioPharma Narrows Losses, Faces Going Concern Doubt — 10-Q · Nov 10, 2025
• Matinas BioPharma Files 8-K: Material Agreement & Equity Sales — 8-K · Aug 18, 2025
• Matinas BioPharma Narrows Losses, Faces Going Concern Doubt — 10-Q · Aug 14, 2025
• Matinas BioPharma Files 8-K for Bylaws and Financials — 8-K · Aug 6, 2025
• Matinas BioPharma Announces Director Changes and Executive Compensation — 8-K · Jun 23, 2025
• Matinas BioPharma Files Q1 2025 10-Q — 10-Q · May 15, 2025
• Matinas BioPharma DEF 14A: Executive Comp Details — DEF 14A · May 12, 2025
• Matinas BioPharma Files 8-K on Governance and Shareholder Matters — 8-K · May 2, 2025
• Matinas BioPharma Files 2024 10-K — 10-K · Apr 15, 2025
• Matinas BioPharma Files 8-K on Equity Sales — 8-K · Apr 8, 2025
• Matinas BioPharma Files 8-K on Shareholder Vote — 8-K · Apr 4, 2025
• Matinas BioPharma Appoints New Directors, Updates Executive Contracts — 8-K · Mar 14, 2025
• Matinas BioPharma Announces Board & Officer Changes — 8-K · Mar 11, 2025
• Matinas BioPharma Files Definitive Proxy Statement — DEF 14A · Mar 3, 2025
• Matinas BioPharma Files 8-K: Agreements, Equity Sales, Officer Changes — 8-K · Feb 13, 2025
• Matinas BioPharma Announces CMO Departure, Director Changes — 8-K · Feb 11, 2025
• Matinas BioPharma CMO Departs, New Interim Appointed — 8-K · Feb 7, 2025
• Matinas BioPharma Announces Board and Executive Changes — 8-K · Jan 24, 2025
• Matinas BioPharma Files 8-K on Listing Rule Concerns — 8-K · Jan 10, 2025